Europe's oncologists back biosimilar versions of cancer drugs
(Reuters) - Europe's leading association of oncologists has thrown its weight behind cheaper copycat versions of biotech cancer drugs that have lost patent protection, saying they are effective and affordable. [Source]
Publication Date:Origin: reuters.com
Category: scienceNews
Topics: drugs, cancer, versions, oncologists, Europe's, affordable, effective, saying, protection, patent, biotech, copycat, cheaper, behind, weight, thrown, association, leading, (Reuters), biosimilar
Source: http://feeds.reuters.com/~r/reuters/scienceNews/~3/PgD3sPTJnak/us-europe-biosimilars-idUSKBN1521QE